Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Gene2Skin

Financiado

Cerrado

Gene2Skin Roadmap for advanced genetic engineering based skin therapies

Skin diseases and disorders are among the most common health problems worldwide and are associated with a considerable burden. It encompasses psychological, social and financial consequences not only on the patients, but also on t... ver más

30/11/2018

UMINHO

992K€

Presupuesto del proyecto: 992K€

Líder del proyecto

UNIVERSIDADE DO MINHO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-11-30

H2020-TWINN-2015: Twinning

I+D

Cerrada hace 9 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UMINHO

530.60K€ | Lider

KINGS COLLEGE LONDON

259.29K€ | Participante

ROYAL COLLEGE OF SURGEONS IN...

202.18K€ | Participante

Proyectos interesantes

BES-2011-043382

Medical Technol...

Biotechnology

43K€ Cerrado

SAF2013-43475-R

Medical Technol...

Data Science

303K€ Cerrado

Holo-GT

Medical Technol...

Genetic Enginee...

2M€ Cerrado

PTQ-09-01-00455

Medical Technol...

Regenerative Me...

60K€ Cerrado

SAF2010-16976

Medical Technol...

Biotechnology

363K€ Cerrado

JCI-2011-09030

Medical Technol...

Biotechnology

96K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 36 meses Fecha Inicio: 2015-11-06
Fecha Fin: 2018-11-30

Líder del proyecto

UNIVERSIDADE DO MINHO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 992K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Skin diseases and disorders are among the most common health problems worldwide and are associated with a considerable burden. It encompasses psychological, social and financial consequences not only on the patients, but also on their families and on society. Chronic and incurable skin diseases/disorders, such as bullous disorders, fibrosis and ulcers, are associated with significant morbidity in the form of physical discomfort and impairment of patients' quality of life; moreover, malignant diseases, such as malignant melanoma and basal cell and squamous cell carcinomas, are associated to substantial mortality. Advances in the field of skin tissue engineering and regenerative medicine have been progressively paving the way to develop innovative therapeutics but much is yet to be achieved. Deeper understanding of the molecular mechanisms underlying these diseases/disorders can be the key to further unravel advanced therapies. By establishing the linking between two of the best European Institutions that complement each other and that are the best in their field of research UMINHO will be able to, with the support of the leading Institutions, start reinforcing the network of collaborations within this field, establishing fruitful partnerships and improve the quality and the innovative nature of the developed research reaching excellence. Per se, these outcomes will promote the strengthening of the interaction between GENE2SKIN partners and will allow taking the research of excellence to the next level by fostering the successive transfer of technology at different levels. Ultimately GENE2SKIN will define a strategic plan to potentiate and propose, respectively under and behind the scope of GENE2SKIN, better and safer advanced therapies for skin disorders/diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores